A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development

Malaria continues to be a pressing global health issue, causing nearly half a million deaths per year. An effective malaria vaccine could radically improve our ability to control and eliminate this pathogen. The most advanced malaria vaccine, RTS,S, confers only 30% protective efficacy under field c...

Descripción completa

Detalles Bibliográficos
Autores principales: Atcheson, Erwan, Hill, Adrian V. S., Reyes-Sandoval, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016880/
https://www.ncbi.nlm.nih.gov/pubmed/33795695
http://dx.doi.org/10.1038/s41541-021-00302-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016880/
https://www.ncbi.nlm.nih.gov/pubmed/33795695
http://dx.doi.org/10.1038/s41541-021-00302-x

Ejemplares similares